These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11439833)

  • 1. The efficacy paradox in randomized controlled trials of CAM and elsewhere: beware of the placebo trap.
    Walach H
    J Altern Complement Med; 2001 Jun; 7(3):213-8. PubMed ID: 11439833
    [No Abstract]   [Full Text] [Related]  

  • 2. Larger effect sizes were associated with higher quality ratings in complementary and alternative medicine randomized controlled trials.
    Bausell RB; Lee WL; Soeken KL; Li YF; Berman BM
    J Clin Epidemiol; 2004 May; 57(5):438-46. PubMed ID: 15196613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methodological issues and complementary therapies: researching intangibles?
    Carter B
    Complement Ther Nurs Midwifery; 2003 Aug; 9(3):133-9. PubMed ID: 12852929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are positive alternative medical therapy trials credible?: Evidence from four high-impact medical journals.
    Barker Bausell R
    Eval Health Prof; 2009 Dec; 32(4):349-69. PubMed ID: 19815600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Roaming through methodology. XXIII. The need for randomization and blinding in therapeutic investigations].
    Knipschild PG
    Ned Tijdschr Geneeskd; 2000 Sep; 144(38):1826-8. PubMed ID: 11020835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of the 'placebo effect' for CAM research.
    Relton C
    Complement Ther Med; 2013 Apr; 21(2):121-4. PubMed ID: 23497816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ethical problems of the clinical placebo use].
    Engelhardt K
    Dtsch Med Wochenschr; 2004 Sep; 129(37):1939-42. PubMed ID: 15372375
    [No Abstract]   [Full Text] [Related]  

  • 8. The importance of preservation of the ethical principle of equipoise in the design of clinical trials: relative impact of the methodological quality domains on the treatment effect in randomized controlled trials.
    Djulbegovic B; Cantor A; Clarke M
    Account Res; 2003; 10(4):301-15. PubMed ID: 14989285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using a randomised controlled trial (RCT) methodology in CAM research with gynaecological cancer patients: A commentary on the perks and pitfalls.
    Archer S; Forshaw MJ
    Complement Ther Clin Pract; 2015 Feb; 21(1):11-8. PubMed ID: 25582376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. For randomized controlled trials, the quality of reports of complementary and alternative medicine was as good as reports of conventional medicine.
    Klassen TP; Pham B; Lawson ML; Moher D
    J Clin Epidemiol; 2005 Aug; 58(8):763-8. PubMed ID: 16018911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. n-of-1 randomized controlled trials: an opportunity for complementary and alternative medicine evaluation.
    Johnston BC; Mills E
    J Altern Complement Med; 2004 Dec; 10(6):979-84. PubMed ID: 15673992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liabilities involved in conducting randomized clinical trials of CAM therapies in the absence of preliminary, foundational studies: a case in point.
    Margolin A
    J Altern Complement Med; 1999 Feb; 5(1):103-4. PubMed ID: 10100036
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies should be controlled, randomized, and blinded.
    Parker RA
    Clin Pharmacol Ther; 2009 May; 85(5):461-3. PubMed ID: 19381148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the quality of surgical trials: further insight.
    Berger VW
    Ann Surg; 2011 Feb; 253(2):420-1; author reply 421. PubMed ID: 21173689
    [No Abstract]   [Full Text] [Related]  

  • 15. Randomized trials and placebo.
    Blair KC
    Adv Mind Body Med; 2003; 19(1):4; author reply 4-5. PubMed ID: 12825407
    [No Abstract]   [Full Text] [Related]  

  • 16. Placebos: our most effective therapy?
    Holbrook A; Goldsmith C
    Can J Clin Pharmacol; 2004; 11(1):e39-40. PubMed ID: 15226525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allocation concealment in RCTs.
    El-Masri MM
    Can Nurse; 2014 Nov; 110(8):10. PubMed ID: 25536693
    [No Abstract]   [Full Text] [Related]  

  • 18. Assessing efficacy of complementary medicine: adding qualitative research methods to the "Gold Standard".
    Verhoef MJ; Casebeer AL; Hilsden RJ
    J Altern Complement Med; 2002 Jun; 8(3):275-81. PubMed ID: 12165185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing allocation concealment and blinding in randomized controlled trials: why bother?
    Schulz KF
    ACP J Club; 2000; 132(2):A11-2. PubMed ID: 10750446
    [No Abstract]   [Full Text] [Related]  

  • 20. The Swiss program for the evaluation of complementary medicine (PEK).
    Walach H
    J Altern Complement Med; 2006 Apr; 12(3):231-2. PubMed ID: 16646720
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.